- Home
- SEE vs IRTC Comparison
SEE vs IRTC Comparison
Compare SEE & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEE
- IRTC
- Stock Information
- Founded
- SEE 1960
- IRTC 2006
- Country
- SEE United States
- IRTC United States
- Employees
- SEE N/A
- IRTC N/A
- Industry
- SEE Major Chemicals
- IRTC Medical/Dental Instruments
- Sector
- SEE Industrials
- IRTC Health Care
- Exchange
- SEE Nasdaq
- IRTC Nasdaq
- Market Cap
- SEE 3.8B
- IRTC 3.1B
- IPO Year
- SEE N/A
- IRTC 2016
- Fundamental
- Price
- SEE $30.57
- IRTC $137.70
- Analyst Decision
- SEE Buy
- IRTC Strong Buy
- Analyst Count
- SEE 12
- IRTC 10
- Target Price
- SEE $37.92
- IRTC $129.90
- AVG Volume (30 Days)
- SEE 1.8M
- IRTC 517.4K
- Earning Date
- SEE 05-06-2025
- IRTC 05-01-2025
- Dividend Yield
- SEE 2.61%
- IRTC N/A
- EPS Growth
- SEE N/A
- IRTC N/A
- EPS
- SEE 2.02
- IRTC N/A
- Revenue
- SEE $5,335,500,000.00
- IRTC $618,587,000.00
- Revenue This Year
- SEE N/A
- IRTC $17.46
- Revenue Next Year
- SEE $2.03
- IRTC $16.93
- P/E Ratio
- SEE $14.90
- IRTC N/A
- Revenue Growth
- SEE N/A
- IRTC 20.54
- 52 Week Low
- SEE $22.78
- IRTC $55.92
- 52 Week High
- SEE $41.14
- IRTC $128.52
- Technical
- Relative Strength Index (RSI)
- SEE 64.71
- IRTC 81.68
- Support Level
- SEE $27.34
- IRTC $103.16
- Resistance Level
- SEE $28.10
- IRTC $140.73
- Average True Range (ATR)
- SEE 0.90
- IRTC 4.73
- MACD
- SEE 0.54
- IRTC 3.63
- Stochastic Oscillator
- SEE 90.87
- IRTC 93.01
About SEE Sealed Air Corporation
Sealed Air is organized via two reporting segments. Food care includes food packaging products like Cryovac, Darfresh, and OptiDure aimed primarily at meats. Product care includes Sealed Air's Bubble Wrap, Instapak, Jiffy mailers, and shrink film packaging systems that cater to industrial and e-commerce applications.
About IRTC iRhythm Technologies Inc.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.